Cytochrome P-450 CYP2D6: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Meg Taylor (subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
{{Image|Mmdbimage-36878.png|right|350px|Crystal Structure of Human Cytochrome P450 2d6.}} | {{Image|Mmdbimage-36878.png|right|350px|Crystal Structure of Human Cytochrome P450 2d6.}} | ||
In [[biology]], the '''cytochrome P-450 CYP2D6''' is a "[[cytochrome P-450]] enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as debrisoquine; [[Adrenergic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This enzyme is deficient in up to 10 percent of the Caucasian population."<ref>{{MeSH}}</ref><ref>{{OMIM|608902}}</ref> | In [[biology]], the '''cytochrome P-450 CYP2D6''' is a "[[cytochrome P-450]] enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as debrisoquine; [[Adrenergic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This enzyme is deficient in up to 10 percent of the Caucasian population."<ref>{{MeSH}}</ref><ref>{{OMIM|608902}}</ref> | ||
Revision as of 07:18, 30 September 2009
In biology, the cytochrome P-450 CYP2D6 is a "cytochrome P-450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as debrisoquine; adrenergic receptor antagonists; and tricyclic antidepressants. This enzyme is deficient in up to 10 percent of the Caucasian population."[1][2]
External links
- OMIM: 124030
- Entrez Gene: 1565; PubMed: search
- Entrez Nucleotide: 68509919; PubMed search
- Entrez Protein: 40805836; PubMed search
- Entrez Structure: 2F9Q
References
- ↑ Anonymous (2024), Cytochrome P-450 CYP2D6 (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 608902. World Wide Web URL: http://omim.org/.